Stage II Gastric Cancer Completed Phase 1 Trials for Oxaliplatin (DB00526)

Also known as: Malignant Neoplasm of Stomach Stage II / Gastric cancer stage II / Gastric malignancy stage II / Stomach cancer stage II

IndicationStatusPhase
DBCOND0030354 (Stage II Gastric Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01561014Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionTreatment